Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 119

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Nitric Oxide-Mediated Histone Hyperacetylation in Oral Cancer: Target for a Water-Soluble HAT Inhibitor, CTK7A

Arif, Mohammed, Vedamurthy, Bhusainahalli M., Choudhari, Ramesh, Ostwal, Yogesh B., Mantelingu, Kempegowda, Kodaganur, Gopinath S., Kundu, Tapas K. · 2010 · Chemistry & Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chembiol.2010.06.014

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 47

  1. Altenberg, 2004, Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes, Genomics, 84, 1014, 10.1016/j.ygeno.2004.08.010 · DOI · Paper page
  2. Anand, 2008, Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature, Biochem. Pharmacol., 76, 1590, 10.1016/j.bcp.2008.08.008 · DOI · Paper page
  3. Asano, 1994, Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells, Proc. Natl. Acad. Sci. USA, 91, 10089, 10.1073/pnas.91.21.10089 · DOI · Paper page
  4. Bai, 2008, Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma, J. Cancer Res. Clin. Oncol., 134, 83, 10.1007/s00432-007-0252-7 · DOI
  5. Balasubramanyam, 2004, Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription, J. Biol. Chem., 279, 51163, 10.1074/jbc.M409024200 · DOI · Paper page
  6. Bandyopadhyay, 2002, Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes, Cancer Res., 62, 6231
  7. Bhaumik, 2007, Covalent modifications of histones during development and disease pathogenesis, Nat. Struct. Mol. Biol., 14, 1008, 10.1038/nsmb1337 · DOI · Paper page
  8. Black, 2006, A mechanism for coordinating chromatin modification and preinitiation complex assembly, Mol. Cell, 23, 809, 10.1016/j.molcel.2006.07.018 · DOI · Paper page
  9. Carrozza, 2003, The diverse functions of histone acetyltransferase complexes, Trends Genet., 19, 321, 10.1016/S0168-9525(03)00115-X · DOI · Paper page
  10. Cole, 2008, Chemical probes for histone-modifying enzymes, Nat. Chem. Biol., 4, 590, 10.1038/nchembio.111 · DOI · Paper page
  11. Czesnikiewicz-Guzik, 2008, NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions, J. Physiol. Pharmacol., 59, 139
  12. Davidson, 2005, The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin, ChemBioChem, 6, 162, 10.1002/cbic.200400246 · DOI
  13. Das, 2009, CBP/p300-mediated acetylation of histone H3 on lysine 56, Nature, 459, 113, 10.1038/nature07861 · DOI · Paper page
  14. Debes, 2003, p300 in prostate cancer proliferation and progression, Cancer Res., 63, 7638
  15. Dimri, 2005, What has senescence got to do with cancer?, Cancer Cell, 7, 505, 10.1016/j.ccr.2005.05.025 · DOI · Paper page
  16. Esteller, 2007, Cancer epigenomics: DNA methylomes and histone-modification maps, Nat. Rev. Genet., 8, 286, 10.1038/nrg2005 · DOI · Paper page
  17. Fraga, 2005, Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer, Nat. Genet., 37, 391, 10.1038/ng1531 · DOI · Paper page
  18. Fukumura, 2006, The role of nitric oxide in tumour progression, Nat. Rev. Cancer, 6, 521, 10.1038/nrc1910 · DOI · Paper page
  19. Gallo, 1998, Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer, J. Natl. Cancer Inst., 90, 587, 10.1093/jnci/90.8.587 · DOI · Paper page
  20. Gayther, 2000, Mutations truncating the EP300 acetylase in human cancers, Nat. Genet., 24, 300, 10.1038/73536 · DOI · Paper page
  21. Grisendi, 2006, Nucleophosmin and cancer, Nat. Rev. Cancer, 6, 493, 10.1038/nrc1885 · DOI · Paper page
  22. Hansson, 2009, The transcriptional coactivator MAML1 regulates p300 autoacetylation and HAT activity, Nucleic Acids Res., 37, 2996, 10.1093/nar/gkp163 · DOI
  23. Hara, 2005, S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding, Nat. Cell Biol., 7, 665, 10.1038/ncb1268 · DOI · Paper page
  24. Huang, 2005, Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity, Mol. Cell. Biol., 25, 6592, 10.1128/MCB.25.15.6592-6602.2005 · DOI · Paper page
  25. Ishihama, 2007, Expression of HDAC1 and CBP/p300 in human colorectal carcinomas, J. Clin. Pathol., 60, 1205, 10.1136/jcp.2005.029165 · DOI · Paper page
  26. Jenkins, 1994, Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation, Br. J. Cancer, 70, 847, 10.1038/bjc.1994.409 · DOI
  27. Kouzarides, 2007, Chromatin modifications and their function, Cell, 128, 693, 10.1016/j.cell.2007.02.005 · DOI · Paper page
  28. Mantelingu, 2007, Specific inhibition of p300-HAT alters global gene expression and represses HIV replication, Chem. Biol., 14, 645, 10.1016/j.chembiol.2007.04.011 · DOI · Paper page
  29. Moncada, 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev., 43, 109, 10.1016/S0031-6997(25)06663-3 · DOI · Paper page
  30. Morimoto, 2008, The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats, J. Clin. Invest., 118, 868
  31. Ota, 2006, Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells, Oncogene, 25, 176, 10.1038/sj.onc.1209049 · DOI · Paper page
  32. Pfister, 2008, The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma, Int. J. Cancer, 122, 1207, 10.1002/ijc.23283 · DOI · Paper page
  33. Ravindra, 2009, Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin, J. Biol. Chem., 284, 24453, 10.1074/jbc.M109.023861 · DOI
  34. Rouaux, 2003, Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration, EMBO J., 22, 6537, 10.1093/emboj/cdg615 · DOI · Paper page
  35. Sambucetti, 1999, Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects, J. Biol. Chem., 274, 34940, 10.1074/jbc.274.49.34940 · DOI · Paper page
  36. Seligson, 2005, Global histone modification patterns predict risk of prostate cancer recurrence, Nature, 435, 1262, 10.1038/nature03672 · DOI · Paper page
  37. Selvi, 2009, Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics, Biotechnol. J., 4, 375, 10.1002/biot.200900032 · DOI
  38. Sen, 2008, Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis, Nat. Cell Biol., 10, 866, 10.1038/ncb1747 · DOI · Paper page
  39. Shandilya, 2009, Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation, Mol. Cell. Biol., 29, 5115, 10.1128/MCB.01969-08 · DOI
  40. Shim, 2002, Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation, Bioorg. Med. Chem., 10, 2439, 10.1016/S0968-0896(02)00116-5 · DOI
  41. Shim, 2004, A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function, Chem. Biol., 11, 1455, 10.1016/j.chembiol.2004.08.015 · DOI
  42. Swaminathan, 2005, Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription, Mol. Cell. Biol., 25, 7534, 10.1128/MCB.25.17.7534-7545.2005 · DOI · Paper page
  43. Szebeni, 1999, Nucleolar protein B23 has molecular chaperone activities, Protein Sci., 8, 905, 10.1110/ps.8.4.905 · DOI · Paper page
  44. Thorne, 2009, Transcription factors, chromatin and cancer, Int. J. Biochem. Cell Biol., 41, 164, 10.1016/j.biocel.2008.08.029 · DOI
  45. Turnell, 2005, The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression, Nature, 438, 690, 10.1038/nature04151 · DOI
  46. Van Beekum, 2007, Aberrant forms of histone acetyltransferases in human disease, Subcell. Biochem., 41, 233
  47. Zhou, 2004, Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein, Nat. Med., 10, 633, 10.1038/nm1050 · DOI

Cited by

See all 119

Metadata

Authors
Arif, M., Vedamurthy, B. M., Choudhari, R., Ostwal, Y. B., Mantelingu, K., Kodaganur, G. S., & Kundu, T. K.
Venue
Chemistry & Biology
Publisher
Elsevier BV
Published
2010-08
Volume
17
Issue
8
Pages
903-913
ISSN
1074-5521
Cited by
119
References
4
Language
en
Licence
Funders
  • Jawaharlal Nehru Centre for Advanced Scientific Research
  • Department of Biotechnology, Government of West Bengal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.